Table 1

Health parameter measurements at baseline and follow-up for intervention and control groups.

Baseline*Follow-up*
InterventionControlInterventionControl
1. Telephone health survey
 Empowerment, quality of life and well-being†
  PEI××××
  SF-12v2××××
  DASS××
  GSE××
  GRS××××
 Socioeconomic status†
  Marital status××
  Education background××
  Occupation××
  Monthly household income××××
 Health service utilisation
  Having a family doctor××××
  Doctor consultation××××
  Emergency department attendance and hospital admission××××
2. Clinical assessment
 Health questionnaire
  Physical activity (IPAQ-short form)××××
  Smoking status××××
  Alcohol consumption××××
  Illicit substance use××××
  Medical history
   History of drug allergy××××
   Current medication××××
   Immunisation record××××
   Previous use of health tests××××
   Medical history××××
   Family history of possible hereditary disease××
  Lower urinary tract symptoms (IPSS and ICIQ UI SF)†××××
  Depression (PHQ-9)‡××××
  Domestic violence (AAS-5†/AAS-2§)××××
 Physical assessments
  Anthropometric measurement
   Weight and height××××
   Waist circumference and hip circumference××××
   Blood pressure and pulse××××
  Vision
   Hyperopia/myopia××××
   Colour blindness (Ishihara Colour Vision Test)××
   Strabismus (Hirschberg test)§××
   Macular degeneration (Amsler grid test)†××××
  Hearing
   PTA××××
   Rinne test××××
   Weber's test××××
  Oral health××××
  Spirometry××××
  Elderly mobility (TUG)¶××××
 Cognitive assessments
  Intellectual ability (WISC-IV-HK-SF)**××
  Behaviour and psychosocial well-being (SDQ and CHQ-50)**××
  Dementia (AMT)¶××××
 Laboratory measures†
  Fasting blood glucose××××
  Lipid profile (total cholesterol, HDL and LDL cholesterol, triglyceride)××××
  Liver function (total bilirubin, ALT, AST, alkaline phosphatase)××××
  Kidney function (urea, creatinine, potassium, sodium)××××
  HBs antigen××××
  Haematology profile (WCC, RBC, haemoglobin, PCV, platelets, MCV, MCH, MCHC)××××
  Differential count (neutrophil, lymphocyte, monocyte, eosinophil, basophil, peripheral blood film)××××
  • *The assessments will be carried out annually in the intervention group, but only at baseline and at the end of the study for controls.

  • †Only apply to participants aged over 18 years.

  • ‡Only apply to participants aged over 14 years.

  • §Only apply to participants aged under 18 years.

  • ¶Only apply to participants aged over 65 years.

  • **Only apply to children studying in grades 1–3.

  • AAS, Abuse Assessment Screen; ALT, alanine aminotransferase; AMT, Abbreviated mental test; AST, aspartate aminotransferase; CHQ, Child Health Questionnaire; DASS, Depression Anxiety Stress Scales; GRS, Global Rating Scales; GSE, General self-efficacy; HDL, high-density lipoprotein; ICIQ UI SF, the International Consultation on Incontinence Questionnaire urinary incontinence short form; IPAQ, International Physical Activity Questionnaire; IPSS, International Prostate Symptom Score; LDL, low-density lipoprotein; MCH, mean cell haemoglobin; MCHC, mean cell haemoglobin concentration; MCV, mean cell volume; PCV, packed cell volume; PEI, patient enablement instrument; PHQ, Patient Health Questionnaire; PTA, Pure tone audiogram; RBC, red blood cell; SDQ, Strengths and Difficulties Questionnaire; SF-12v2, Short-Form Health Survey—the second version; TUG, Timed up and go; WCC, White cell count; WISC-IV-HK-SF, Wechsler Intelligence Scale for Children—Hong Kong (Short Form).